Internet Archive Scholar

REAL-WORLD USE OF RITUXIMAB IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE STUDY OF A SINGLE-CENTER IN RIO DE JANEIRO

Elisa Benicio Henriques, Camila Souza das Chagas Nogueira, Manuella Lima Gomes Ochtrop, Leticia Rocha Pereira, Guilherme Rodrigues Brezenski, Talita Gonçalves Pereira de Souza, Juliana Murad Faria
2021 Anais do Congresso Brasileiro de Reumatologia 2020   unpublished

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (413.4 kB)
https://web.archive.org/web/20210120020040/http://reumatologia.org.br/downloads/anais/%28R%29%2017465.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL. The file type is application/pdf.

BACKGROUND Rituximab (RTX) is a well-established biological disease modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) not responding adequately to synthetic DMARDs. The aim of this study was to describe clinical and laboratory characteristics of RTX in Brazilian patients with RA.
doi:10.47660/cbr.2020.17465 fatcat:y6ulnxgrnrgezh3ekned47twma
Citation

Elisa Benicio Henriques, Camila Souza das Chagas Nogueira, Manuella Lima Gomes Ochtrop, Leticia Rocha Pereira, Guilherme Rodrigues Brezenski, Talita Gonçalves Pereira de Souza, Juliana Murad Faria. "REAL-WORLD USE OF RITUXIMAB IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE STUDY OF A SINGLE-CENTER IN RIO DE JANEIRO." Anais do Congresso Brasileiro de Reumatologia 2020 (2021)